Genetic factors play an important role in the etiology of idiopathic dilated cardiomyopathy, with mutations detected in genes encoding sarcomere, cytoskeletal, and nuclear proteins.
This review highlights the heterogeneous genetic basis of dilated cardiomyopathy, emphasizing the potential for early targeted treatment and novel therapeutic modalities.
Dilated cardiomyopathy (DCM) is a myocardial disease characterized by dilatation and impaired systolic function of the left or both ventricles. The etiology of DCM is multifactorial, and many different clinical conditions can lead to the phenotype of DCM. During recent years it has become evident that genetic factors play an important role in the etiology and pathogenesis of idiopathic DCM. The genetics of DCM have been under intensive investigation lately, and thereby the knowledge on the genetic basis of DCM has increased rapidly. The genetic background of the disease seems to be relatively heterogeneous, and the disease-associated mutations concern mostly single families and only few affected patients. Disease-associated mutations have been detected e.g. in genes encoding sarcomere, cytoskeletal, and nuclear proteins, as well as proteins involved with regulation of Ca(2+) metabolism. The mechanisms, by which mutations eventually result in clinical heart failure, are complex and not yet totally resolved. DCM causes considerable morbidity and mortality. Better knowledge of the genetic background and disease-causing mechanisms would probably help us in focusing early treatment on right subjects and potentially also developing new treatment modalities and improving cardiac outcome in the affected patients. This review deals with DCM of genetic origin.
Kärkkäinen et al. (2007) conducted a review in Dilated cardiomyopathy (DCM). Genetic factors play an important role in the etiology of idiopathic dilated cardiomyopathy, with mutations detected in genes encoding sarcomere, cytoskeletal, and nuclear proteins.